Searched for
BETA DRUGS EXPANSION
Ignore volatility and look for long-term opportunities: 5 mid-cap stocks from different sectors with upside potential of over 23%- Largecap stocks and financial sectors offer the most value in short time: Sushant Bhansali
- For risk-takers with a long-term perspective: 1 small and 7 mid-cap stocks from different sectors with upside potential of up to 44%
- Beta Drugs raises Rs 117 crore from HealthQuadBeta Drugs secured Rs 117 crore from HealthQuad and other investors to expand globally and boost operational capabilities. The oncology-foc...27 Nov, 2024, 09.34 PM IST
- Volatility or opportunity, depends on stock & your ability: 5 mid-cap stocks from different sectors with an upside potential of up to 42%The market is volatile with a bearish bias, and the chances that it will remain so for some time are high. But then volatility is not new, ...18 Nov, 2024, 03.50 PM IST
- Medtech startup SigTuple raises $4 million from Sidbi Venture Capital, othersThe startup, which specialises in digital microscopy solutions powered by AI and robotics, has raised $50 million to date. The new capital ...06 Aug, 2024, 11.50 PM IST
- Forget additional 2.5% LTCG, finally it is economy and earnings: 4 midcap stocks from different sectors with an upside potential of up to 37%The reaction of the street to the increase in both short and long capital gains tax is stronger because it was not expected by any section ...24 Jul, 2024, 12.40 PM IST
- Focus on capital protection in volatile times: 4 midcap stocks with potential upside of up to 39%In equity markets, whatever precaution one might take, the probability of a mistake of getting stuck with a wrong stock cannot be ruled out...31 Mar, 2024, 12.45 PM IST
- With more checks and balances for better risk management: 4 midcap stocks with potential upside of up to 25%After a relentless rally for the last ten months, the mid-caps segment of the market is witnessing some profit booking/ correction/ rationa...12 Mar, 2024, 04.00 PM IST
- Is the worst behind them? 5 agrochemical stocks with upside potential of up to 38%Majority of businesses have a cycle of ups and downs. The question is whether the downs are cyclical in nature or they have come up due to ...11 Mar, 2024, 09.11 AM IST
- Is the worst of headwinds behind them? 5 agrochemical stocks with upside potential of up to 32%While they had been listed for a long period of time, Indian companies in agro chemical space got the real attention of the street only fou...06 Mar, 2024, 03.40 PM IST
- In the short term, IT and banking to benefit most as FIIs return: Rajat Sharma“High beta stocks – IT and banking – tend to do really well when there is a lot of foreign money coming in and they suffer the most when th...11 Aug, 2022, 11.33 AM IST
- Drug used to reduce blood fats may cut SARS-CoV-2 infection by 70 per cent: StudyThe team led by researchers from the University of Birmingham in the UK found that fenofibrate and its active form fenofibric acid can sign...06 Aug, 2021, 12.45 PM IST
- Stocks in the news: Infosys, Allahabad Bank, DHFL, SBI, Jet and Sun PharmaMorgan Stanley has double upgraded Sun Pharma stock, ET Now reported.15 Jul, 2019, 08.20 AM IST
- Select low-beta stocks may be better bets in this marketFive stocks to look at in the current market scenario marked by uncertainties.23 Mar, 2018, 10.21 AM IST
- Global brokerages positive on banking, pharma sectors; five stocks to bet onIn the past week, the beta rally lost steam. Here are the top four recommendations from various brokerage firms for a minimum investment pe...06 Apr, 2016, 12.58 PM IST
- Market will be happy if RBI hikes repo rate and cuts MSF rate: Nilesh Shah, Axis DirectEven if Raghuram Rajan hikes the repo rate and lowers the MSF rate, the market will be more than happy, says Nilesh Shah.19 Sep, 2013, 06.38 PM IST
- Markets want Narendra Modi as the next PM: Manish Sonthalia, VP & Fund Manager, Motilal Oswal Asset Management'Valuations are beaten down for the bulk of the market, but visibility is not there and where the visibility is you get stocks at reasonabl...03 Sep, 2013, 06.20 PM IST
- Markets willing to pay premium for good earnings growth: Jitendra Sriram, HSBC Securities"Yesterday’s selling was a bit of a surprise. A lot of it has to do with the amount of arbitrage money sloshing around in the Indian system...14 May, 2013, 01.24 PM IST
- Rel Life Sciences to focus on R&D, for nowThe company is all set to launch fifth biosimilar drug and seeks approvals for clinical trials and stem-cell treatment.13 Jul, 2010, 04.09 AM IST
Load More
